CCL2 and Alzheimer disease: Irisins might exert neuroprotective effects in AD by modulating several molecular mechanisms, including the suppression of necroptosis via pathways involving TNF-α signaling, HMGB1/MCP1-mediated inflammation, and BDNF regulation.